Belite Bio (BLTE) Tops Q1 EPS by 10c

Belite Bio (NASDAQ: BLTE) reported Q1 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Redwood Trust reports record Aspire quarter, launches AI pricing tools
• DigitalOcean projects record Q2 2026 results with RPO above $800M
• UBS Reiterates Buy Rating on Deckers Outdoor (DECK), Expects Uneventful Q1 Results